Koneksa Health Funding: $65M Raised, Series C (2022)
Koneksa Health is based in New York, NY. It has raised $65M in total funding. Latest round: Series C.
Koneksa Health funding overview
Koneksa Health is based in New York, NY. Koneksa Health has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in February 2022. The round record for Koneksa Health runs through 2022; nothing later has been disclosed. Investors on record include Matrix Capital Management, 4BIO Capital, Takeda Ventures, McKesson Ventures, Merck, Novartis and 3 others. 9 distinct backers are named across the disclosed rounds.
Koneksa Health at a glance
Total raised
$65M
Latest round
Series C
Latest round date
February 2022
Headquarters
New York, NY
Notable investors
Matrix Capital Management, 4BIO Capital, Takeda Ventures, McKesson Ventures, Merck, Novartis, Spring Mountain Capital, Waterline Ventures
Frequently asked about Koneksa Health funding
How much has Koneksa Health raised?
Koneksa Health has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Koneksa Health?
Matrix Capital Management, 4BIO Capital, Takeda Ventures, McKesson Ventures, Merck, Novartis are named among the investors backing Koneksa Health.
What was the latest Koneksa Health funding round?
The most recent disclosed round is a Series C, announced in February 2022.
Where is Koneksa Health based?
Koneksa Health is based in New York, NY.
When did Koneksa Health last raise?
The last disclosed Koneksa Health round closed in February 2022 at Series C.
Koneksa Health totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.
